Tridol Injection 100 Milligrams (Tramadol Hydrochloride)

Adult administration

As Tramadol Hydrochloride, administer 50-100mg via intravenous or intramuscular injection as needed, repeating every 4-5 hours. The maximum daily dose is 400mg.

This medication may lead to seizures if dosed beyond the recommended amount, so it should not exceed 400mg per day. Additionally, patients with a risk of seizures or epilepsy should use this medication only when absolutely necessary. Long-term use may lead to psychological and physical dependence, so patients with a history of drug abuse or dependence should be strictly monitored and limited to short-term use. This medication, when taken with alcohol or central nervous system depressants, can cause severe drowsiness, respiratory depression, and coma, so co-administration should be avoided or used with extreme caution. Patients who metabolize this medication rapidly due to genetic factors may have an increased risk of respiratory depression, requiring careful monitoring and dosage adjustment. This medication should not be administered to children under 12 years of age or adolescents under 18 years of age who have undergone tonsillectomy or adenoidectomy. Adolescents aged 12 to 18 should also avoid it if specific risk factors are present. Patients with sleep apnea or hypoxia should closely monitor for the worsening of symptoms while taking this medication and should reduce or discontinue the dose if necessary. This medication should not be given to patients with acute alcohol intoxication, severe respiratory depression, head injury, patients on MAO inhibitors, severe liver or kidney impairment, or to pregnant or breastfeeding women. Due to many drug interactions, careful monitoring and dosage adjustments are needed when taken with other central nervous system depressants, antidepressants, anticoagulants, etc. If symptoms such as drowsiness, dizziness, or difficulty breathing occur during use, immediate consultation with a healthcare provider is essential. During medication use, avoid driving or operating hazardous machinery, and be aware that sudden discontinuation may induce withdrawal symptoms, therefore dosage should be gradually reduced. In case of overdose, severe respiratory depression and seizures may occur, requiring immediate emergency treatment, with naloxone potentially being used as an antidote. Store this medication out of reach of children and in the original container to prevent degradation of quality and misuse.

Serious side effects

Seizures, severe allergic reactions (hives, shock, anaphylaxis, angioedema, bronchospasm), respiratory depression, difficulty breathing, worsening of asthma, facial pallor, cardiovascular issues (cardiovascular effects, arrhythmia, severe blood pressure elevation), fainting, severe headache, liver abnormalities (elevated liver enzyme levels), Stevens-Johnson syndrome, severe skin reactions (severe rashes, blisters, skin peeling, mucosal pain), serious neurological symptoms (seizures)

Mild side effects

• Nausea
• vomiting
• drowsiness
• dizziness
• staggering
• palpitations
• coldness
• mental distress
• vasodilation
• hypotension

This medication should be stored in a sealed container to prevent exposure to air or moisture. It is recommended to maintain the storage temperature between 1 degree and 30 degrees Celsius at room temperature. Storing it this way helps maintain its efficacy and safety.

Appearance

A colorless and odorless clear liquid filled in a colorless and transparent ampoule

Package unit

2ml/ampoule x 50